Market Overview

UPDATE: Jefferies Raises PT on PAREXEL on Tough Margin Outlook, Premium Valuation

Share:
Related PRXL
10 Stocks That Rallied Four Days, Then Sold Off Yesterday
Benzinga's Top Downgrades
Valuation Dashboard: Healthcare - Update (Seeking Alpha)

In a report published Thursday, Jefferies analyst David Windley reiterated a Hold rating on PAREXEL (NASDAQ: PRXL), and raised the price target from $41.00 to $43.00.

In the report, Jefferies noted, “PRXL's revenue growth will slow markedly over the next year. Reaccelerating in FY15 will require more strategic deals. By contrast, margin expansion will have to accelerate to offset the revenue slowdown. That will be challenged by the low-margin impact of new strategic deals. The tough margin outlook and a premium valuation keeps us sidelined. PT to $42.”

PAREXEL closed on Wednesday at $46.17.

Latest Ratings for PRXL

DateFirmActionFromTo
Nov 2016Wells FargoDowngradesOutperformMarket Perform
Nov 2016JefferiesMaintainsHold
Nov 2016SunTrust Robinson HumphreyDowngradesBuyHold

View More Analyst Ratings for PRXL
View the Latest Analyst Ratings

Posted-In: David Windley JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (PRXL)

View Comments and Join the Discussion!